This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Lactobacillus delbrueckii bulgaricus
- DrugBank Accession Number
- DB16540
- Background
Not Available
- Type
- Small Molecule
- Groups
- Approved, Experimental
- Synonyms
- Lactobacillus bulgaricus
- Lactobacillus delbrueckii ssp bulgaricus
- Lactobacillus delbrueckii subsp. bulgaricus
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
Avoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events & improve clinical decision support.- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Acidophilus Bifidum Bulgaricus Lactobacillus delbrueckii bulgaricus (120 mg) + Bifidobacterium bifidum (120 mg) + Lactobacillus acidophilus (120 mg) Capsule Oral Nutraceutical Corporation 2003-09-02 2006-08-02 Canada 
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- HU1W4L947H
- CAS number
- Not Available
- InChI Key
- Not Available
- InChI
- Not Available
- IUPAC Name
- Not Available
- SMILES
- Not Available
References
- General References
- Not Available
- External Links
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 4 Completed Treatment Bacterial Vaginosis (BV) / Recurrences 1 4 Completed Treatment Diarrhoea Predominant Irritable Bowel Syndrome 1 4 Completed Treatment Probiotics / Type 1 Diabetes Mellitus 1 4 Not Yet Recruiting Treatment Chronic Sinusitis 1 4 Not Yet Recruiting Treatment Type 2 Diabetes Mellitus With Complication 1 4 Recruiting Treatment Bacterial Vaginosis (BV) 1 4 Recruiting Treatment Basal Ganglia Diseases / Brain Disorders / Central Nervous System Disorder / Diseases of the Nervous System / Motor Skills Disorders / Neurodegenerative Disorders / Parkinson's Disease (PD) / Parkinsonian Syndromes 1 4 Recruiting Treatment Colonoscopy / Functional Constipation (FC) / Irritable Bowel Syndrome (IBS) / Probiotics 1 4 Recruiting Treatment Recurrent Vulvovaginal Candidiasis 1 4 Recruiting Treatment Transitional Cell Carcinoma of the Bladder 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Capsule Oral Powder, for suspension Oral Tablet Oral - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
- Not Available
- Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Not Available
Drug created at February 03, 2021 16:01 / Updated at March 03, 2021 21:58